Sponsored by Lane Powell
Home Back Issues April 2011 A stronger surgical seal

A stronger surgical seal

| Print |  Email
Articles - April 2011
Tuesday, March 22, 2011
0411_NextA product made from naturally occurring human fibrinogen (a soluble plasma glycoprotein), Gamma Prime Fibrinogen, is under development as a high-strength surgical sealant that resists being broken down by the body and would have the ability to withstand higher blood pressure in vascular wounds. “With a lot of sealants used today the body’s natural enzymes break them down,” says David Eastman, CEO of Gamma Therapeutics, the Portland-based biotech company that is developing the sealant. Built on research by Dr. David Farrell, an OHSU professor and founder of Gamma Therapeutics, the sealant can be sprayed or dripped onto a wound, and once dissolved with water the clotting process to form the seal begins. Farrell says the sealant would be most useful where there is significant tissue damage, such as from trauma surgeries and hip or knee replacements. A patent is pending for the Gamma Seal while grant requests are being made to the National Institutes of Health and the Department of Defense.
MAX GELBER
 

More Articles

Gender Code

September 2014
Tuesday, August 26, 2014
BY COURTNEY SHERWOOD

Janice Levenhagen-Seeley reprograms tech.


Read more...

Back to School

September 2014
Wednesday, August 27, 2014
BY LEE VAN DER VOO

By now we’ve all read the headlines: Starbucks is giving away free degrees. Except it isn’t.


Read more...

The Scott Kveton affair

News
Wednesday, July 09, 2014
ScottKvetonBY LINDA BAKER | OB EDITOR

Scott Kveton, the CEO of Urban Airship is taking a leave of absence from the company. As the story continues to unfold, here’s our perspective on a few of the key players.


Read more...

The Alchemist

September 2014
Tuesday, August 26, 2014
BY LINDA BAKER

David Howitt explains why Portland consumer brands like Stumptown and Voodoo Doughnuts are taking the world by storm.


Read more...

Updated: Disrupting innovation

News
Tuesday, July 08, 2014
070814 thumb disputive-innovationBY LINDA BAKER  | OB EDITOR

The New Yorker recently published a sharply worded critique of “disruptive innovation,” one of the most widely cited theories in the business world today. The article raises questions about the descriptive value of disruption and innovation  — whether the terms are mere buzzwords or actually explain today's extraordinarily complex and fast changing business environment. 

Update: We caught up with Portland's Thomas Thurston, who shared his data driven take on the disruption controversy.


Read more...

Private liberal arts education: superior outcomes, competitive price

Contributed Blogs
Tuesday, August 26, 2014
0826 thumb collegemoneyBY DEBRA RINGOLD | OP-ED CONTRIBUTOR

Why has six years become an acceptable investment in public undergraduate education that over-promises and underperforms?


Read more...

Oversight? Or gaming the system?

News
Monday, July 14, 2014
AmazonBY VIVIAN MCINERNY | OB BLOGGER

Some people think Amazon’s winking eye logo is starting to look like a hoodwink.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS